It’s only money, says the billion dollar Japanese Pharma giant Takeda.
Bloomberg is reporting today that Takeda is now offering $2.3 billion – $100 million more than was offered on April 1, 2015 – to settle the 8,000 Actos cases currently on file in state and federal courts across the U.S. This is equal to $287,500 per case which figures to be only $12,500 more per case than their previous offer.
Takeda directors still must vote on the amount and terms of the settlement said the people, who asked not to be identified because they weren’t authorized to speak publicly about the settlement.